Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(7%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_4
1
7%
Ph phase_3
1
7%
Ph phase_1
1
7%
Ph not_applicable
6
43%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(6)
Other(5)

Detailed Status

Completed6
unknown5
Enrolling by invitation2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A6 (66.7%)

Trials by Status

completed643%
recruiting17%
unknown536%
enrolling_by_invitation214%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
OTHER
Total Trials
14